Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
538.9 USD | -0.39% | +0.09% | +14.29% |
Jun. 04 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Jun. 04 | Sector Update: Health Care | MT |
Financials (USD)
Sales 2024 * | 171B | Sales 2025 * | 182B | Capitalization | 125B |
---|---|---|---|---|---|
Net income 2024 * | 8.06B | Net income 2025 * | 9.07B | EV / Sales 2024 * | 0.83 x |
Net Debt 2024 * | 17.34B | Net Debt 2025 * | 13.7B | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
13.6
x | Employees | 104,900 |
Yield 2024 * |
1.17% | Yield 2025 * |
1.26% | Free-Float | 99.6% |
Latest transcript on Elevance Health, Inc.
1 day | -0.39% | ||
1 week | +0.09% | ||
Current month | +0.09% | ||
1 month | +0.52% | ||
3 months | +7.45% | ||
6 months | +12.99% | ||
Current year | +14.29% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 13-09-30 | |
Director/Board Member | 55 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 21 M€ | +8.41% | - | |
2.36% | 1,184 M€ | +9.78% | - | |
2.07% | 7 M€ | +5.53% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 538.9 | -0.39% | 742,381 |
24-06-06 | 541 | +0.19% | 615,037 |
24-06-05 | 540 | -0.08% | 650,835 |
24-06-04 | 540.4 | -0.42% | 1,246,528 |
24-06-03 | 542.7 | +0.79% | 1,238,220 |
Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 125B | |
-6.80% | 452B | |
+12.91% | 96.05B | |
-23.16% | 42.39B | |
-5.93% | 37.25B | |
-14.32% | 18.14B | |
-25.77% | 2.63B | |
+15.53% | 546M |
- Stock Market
- Equities
- ELV Stock